Influencing value frameworks and assessments2018-02-15T14:43:33+00:00

Influencing value frameworks and assessments

PHE offers thought leadership in the debate on future directions of value framework methodologies.

  • PHE authors have published numerous articles on value framework methodologies in leading policy and medical journals, including the Journal of the American Medical Association (JAMA), New England Journal of Medicine (NEJM) and Health Affairs
  • Darius Lakdawalla and Peter Neumann served on the International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR’s) Initiative on US Value Assessment Frameworks special task force in 2016 and 2017
  • Peter Neumann served as co-chair of the 2nd Panel on Cost-Effectiveness in Health and Medicine, which led to updated guidelines on value assessment, published in JAMA
  • Wade Aubry serves on the advisory board of the California Technology Assessment Forum (CTAF)

Applying this expertise in value assessments, PHE conducts critical appraisals of health technology assessments and value frameworks ensuring that methods used by technology assessment organizations are accurate and comprehensive. PHE specializes in rapid-response reviews to meet deadlines for public comment and in recreation of models to assess model validity.

PHE has partnered with clients on responses to over 20 Institute for Clinical and Economic Review (ICER) assessments, which have had meaningful impacts on ICER’s final recommendations, including several reversals. We have also conducted thorough assessments of value framework methodologies developed by organizations such as the American Society for Clinical Oncology (ASCO).

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.